# Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder

> **NCT01504659** · PHASE2,PHASE3 · TERMINATED · sponsor: **Juvenile Bipolar Research Foundation** · enrollment: 5 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Ketamine hydrochloride injection
- **DRUG:** Flat tonic water (e.g., Canada Dry Tonic Water)

## Key facts

- **NCT ID:** NCT01504659
- **Lead sponsor:** Juvenile Bipolar Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Administrative issues
- **Last updated:** 2017-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01504659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01504659, "Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01504659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*